Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05289570 · ClinicalTrials.gov registry record · Phase 2
Voxelotor for Improving Oxygen Saturation in Adults
A Phase 2 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT05289570 is a Phase 2 study that was terminated before completion, run by Duke University. The registered enrollment target is 3 participants.
The verdict
NCT05289570, a Phase 2 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy of voxelotor for increasing oxygen saturation in 20 patients with hypoxemia. Specifically, the SpO2/FiO2 ratio will be compared before and after voxelotor use at rest and during exercise (ambulatory patients only). The primary study objective is to evaluate the efficacy of voxelotor for increasing oxygen saturation in patients with hypoxic hypoxemia as a result of end-stage lung disease or acute lung injury. The secondary objective is to evaluate the efficacy of voxelotor on allowing de-escalation of supplemental oxygen support.
Interventions
- DRUG Voxelotor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-05-03 |
| Est. Completion | 2023-07-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05289570
The ClinicalTrials.gov registry entry for NCT05289570 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Voxelotor is the first listed.
NCT05289570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05289570 about?
NCT05289570 is a clinical study titled "Voxelotor for Improving Oxygen Saturation in Adults". The purpose of the study is to evaluate the efficacy of voxelotor for increasing oxygen saturation in 20 patients with hypoxemia. Specifically, the SpO2/FiO2 ratio will be compared before and after voxelotor use at rest and during exercise (ambulatory patients only). The primary study objective is ...
What is the current status of trial NCT05289570?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2022-05-03. Estimated completion is 2023-07-04.
What interventions are being tested in trial NCT05289570?
The interventions under investigation include: Voxelotor (DRUG).
Who is sponsoring clinical trial NCT05289570?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.